Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vsee Health (VSEE) EPS (Weighted Average and Diluted) (2023 - 2025)

Vsee Health's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.31 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 135.23% year-over-year to -$0.31; the TTM value through Dec 2025 reached -$0.73, up 75.25%, while the annual FY2025 figure was -$0.73, 87.08% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.31 in Q4 2025 per VSEE's latest filing, down from -$0.02 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.88 in Q4 2024 to a low of -$3.58 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$0.35, with a median of -$0.11 recorded in 2023.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 438.46% in 2024 against a maximum downside of 17800.0% in 2024.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.26 in 2023, then skyrocketed by 438.46% to $0.88 in 2024, then crashed by 135.23% to -$0.31 in 2025.
  • Per Business Quant, the three most recent readings for VSEE's EPS (Weighted Average and Diluted) are -$0.31 (Q4 2025), -$0.02 (Q3 2025), and -$0.16 (Q2 2025).